B-type Raf Kinase (BRAF) mutations are well-known oncogenic drivers associated with various solid tumors including thyroid carcinoma, colorectal carcinoma, melanoma, ovarian cancer, and others [7]. This evidence concerns the gene BRAF and thyroid gland carcinoma.